Advertisement

Topics

STEM-Pharma Company Profile

12:00 EDT 25th June 2018 | BioPortfolio


News Articles [1606 Associated News Articles listed on BioPortfolio]

Midatech Pharma kicks off stem cell transplant side-effect trial

Midatech Pharma on Friday announced that it has enrolled the first patient in its study concerning the effects of Gelclair on the oral mucosits in patients undergoing stem cell transplant (SCT) the...

Could the Microbiome Treat Side Effects of Stem Cell Transplants?

MaaT Pharma, based in Lyon, has received authorization to launch a Phase II trial for its therapy, which targets the gut microbiota to treat complications from stem cell transplants. MaaT Pharma will ...

#news #biotech A personalized MS treatment built from skin stem cells

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: A personalized MS treatment built from skin stem cells .Scientists at the Uni...

Astellas Buys Stem Cell Gene-Editing Firm Universal Cells for $102.5M

A Seattle-based company developing a universal source of stem cells for cell therapies has been acquired by Tokyo-based Astellas Pharma for $102.5 million. Universal Cells’ technology aims to make s...

Stem Cells: the Basics

(U.S. News & World Report) – Stem cells are packed with possibility. Embryonic or “pluripotent” stem cells have superpowers: They can give rise to various organs or tissue cells,...

BioLamina and Novo Nordisk announce stem cell collaboration

BioLamina has announced a partnership with Danish pharma Novo Nordisk to develop stem cell-based therapies based on Biolaminins, human recombinant...Read More... The post BioLamina and Novo Nordisk an...

Scientists develop a 'third eye' to examine stem cells

(Moscow Institute of Physics and Technology) The researchers employed the triple labeling technique to analyze stem cells in the brain, the intestine, and testis, using additional tricks to effectivel...

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Drugs and Medications [510 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [1657 Associated PubMed Articles listed on BioPortfolio]

Moving pharma contracting into the era of accountability.

Stem cells as vehicles and targets of nanoparticles.

Modulation of endogenous adult stem cell niches represents a promising strategy for regeneration of tissues and to correct cell abnormalities, including cancer. Recent advances show the possibility to...

Tracing Stem Cell Division in Adult Neurogenesis.

Neural stem cells in the ventricular-subventricular zone of the adult brain continuously generate differentiated neurons without depleting the stem cell pool. In this issue of Cell Stem Cell, Obernier...

A New Stem Cell Biology: Transplantation and Baseline, Cell Cycle and Exosomes.

Hematopoietic stem cell biology has focused on stem cell purification and the definition of the regulation of purified stem cells in a hierarchical system. Work on the whole unpurified murine marrow c...

Quiescent Tissue Stem Cells Evade Immune Surveillance.

Stem cells are critical for the maintenance of many tissues, but whether their integrity is maintained in the face of immunity is unclear. Here we found that cycling epithelial stem cells, including L...

Clinical Trials [2710 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [1054 Associated Companies listed on BioPortfolio]

Kiadis Pharma

Kiadis Pharma is an oncology focused biopharmaceutical company developing products that offer novel treatment options for terminally ill cancer patients addressing significant unmet medical needs. Th...

STEM-Pharma

Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The ...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

Stem Cell Sciences plc

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK ...

More Information about "STEM-Pharma" on BioPortfolio

We have published hundreds of STEM-Pharma news stories on BioPortfolio along with dozens of STEM-Pharma Clinical Trials and PubMed Articles about STEM-Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of STEM-Pharma Companies in our database. You can also find out about relevant STEM-Pharma Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record